Depomed, Inc. And Madaus Enter Into Agreement For ProQuin XR In Europe

Published: Nov 29, 2005

MENLO PARK, Calif. & PADOVA, Italy--(BUSINESS WIRE)--Nov. 29, 2005--Depomed, Inc. (Nasdaq: DEPO) and Madaus S.r.l. today announced that the companies have entered into a distribution and supply agreement for ProQuin(R) XR, Depomed's once-daily, extended release formulation of the antibiotic ciprofloxacin.

Back to news